A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
about
Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cellsRationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor CellsInduction of pluripotency by defined factorsTranscription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogrammingMiniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.Timely inhibition of Notch signaling by DAPT promotes cardiac differentiation of murine pluripotent stem cellsCell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseaseChoices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming StrategiesImmortalization eliminates a roadblock during cellular reprogramming into iPS cellsStemness factor Sall4 is required for DNA damage response in embryonic stem cellsReprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factorsMEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription FactorEfficient generation of iPS cells from skeletal muscle stem cellsParkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factorsGenetic engineering of human pluripotent cells using TALE nucleasesEfficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleasesNipbl Interacts with Zfp609 and the Integrator Complex to Regulate Cortical Neuron Migration.Regeneration and reprogramming compared.Gene-delivery systems for iPS cell generation.The effect of substrate topography on direct reprogramming of fibroblasts to induced neuronsEWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells.Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs.The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiationFunctional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genomeDeterministic direct reprogramming of somatic cells to pluripotency.A comprehensive system for generation and evaluation of induced pluripotent stem cells using piggyBac transposition.Reprogramming of human peripheral blood cells to induced pluripotent stem cells.The Ink4a/Arf locus is a barrier to direct neuronal transdifferentiationInduced pluripotency: history, mechanisms, and applications.Accessing naïve human pluripotency.Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.Systematic identification of culture conditions for induction and maintenance of naive human pluripotency.Direct reprogramming of human fibroblasts toward a cardiomyocyte-like stateDirect activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors.Generation of a drug-inducible reporter system to study cell reprogramming in human cells.The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells.Modulation of pluripotency in the porcine embryo and iPS cells.
P2860
Q54898201-D99B220A-128C-49C7-97EB-AB8AA984DF0DQ54898202-64F3D765-CC26-4127-AD99-FF1C198E8F84Q54898203-12187E1F-4796-4F06-A28E-1EC1F3DA85D9Q54898204-D9C013A3-43F3-4346-8B6D-DEE1D762A6AAQ54898205-BF0980CA-B407-4D91-A4FC-986EA5437AB7Q54898206-7B135614-E1CC-4FF0-8A76-A8AA056073E9Q54898211-D4DE825D-6D3A-4589-8D87-FA03BC86E762Q54898212-35285E90-F520-4EAF-B7B6-482C9EB79D10
P1343
Q24620932-1993F057-A16F-4665-91B6-6D7CFF70064DQ26750951-E44E7055-AB08-40F7-9DE5-8F684C6074DAQ26830425-DC8B56B4-86A7-4BF8-8AC7-1B64D1461214Q27320356-8F54AD6E-09D2-4E62-B175-0BF5B95ECC0CQ27320368-CCA04B16-EEDB-42F6-A1EC-4D5758E8E9BDQ27339354-EFA48FAC-34A2-425B-9F21-D33759A0F013Q28080770-9CDDF640-5F83-45A9-9CCB-F371C1D75A23Q28085565-8125A657-AB11-428E-ADF8-8A139A1B477FQ28254388-1DF28237-533A-4D77-B327-F5748CCF416FQ28258177-501D0BAC-966C-4DD5-A535-71E7268BB245Q28476699-38FB291B-0F49-4281-88E6-842743D9132AQ28547784-992E03C5-7C9F-4E43-99E1-95D7A895C661Q28743774-B8BC8051-C826-493B-99F0-0F46A2CFD3F7Q28749672-86EC3273-FA75-47A9-8284-1905FB5A957DQ29619830-ECB82E6B-3B36-4DDA-AEF3-0EABC61F6203Q29622846-1160C756-EF08-43D4-A28A-62762C44258EQ33112262-7D080892-3130-4C69-8BE2-C1DE90B55861Q33525370-47EDD561-95AE-4A2B-9FCE-1502D9284B5EQ33611081-DEE8563B-4082-4334-BAEC-CE17D9316756Q33623601-A22BFDD4-E8AA-49A3-9140-DB16B5FE5E20Q33630894-D1784C65-DBDD-4416-9BA5-EC7371DBF9DFQ33700366-4ED63B90-1366-4D59-8312-91AD70F56EEAQ33729666-EE933F9F-04E7-4614-A7E9-9716C744432CQ33927236-089CF272-5D6D-4F4A-AB0B-B3C2872C2582Q33952905-0AE83C53-5731-4331-88FC-E4CA4581FD8CQ34018343-89BBAFC8-543E-44BF-8EA9-9FCFF0C791A2Q34034406-33193065-A70A-4D65-91B2-141D218A111FQ34038235-73454A54-3310-40AA-91D7-C81823D20B3FQ34040322-DD72A646-D98B-4752-8DE7-7BF01B80DE1DQ34048915-D56C455D-4340-4914-9F4F-964AA6D6E32AQ34162817-60235A13-DE72-42FB-9078-3ED6DFF4EDD2Q34206028-1392FD69-41E3-4B3D-8C0A-13A91ABE7AB8Q34224132-ED60EE1C-1C37-4A07-93DA-19218F91DD4EQ34280164-02B942CE-EC2C-4CD0-9B73-D9876BC5ECB6Q34288016-5822A02A-0D74-464F-88F7-AE702AA8382FQ34390637-A90D143A-5F94-4A2C-AAE5-3E7B23BC1277Q34402571-220E7A98-7003-437C-9D02-AB128E1082CFQ34423562-0AC2E520-3849-4837-9C9C-4BC81927ACFCQ34444238-AD44EEB0-B740-4899-917D-72B18EB7E4F1Q34474003-DEFDB8BB-596E-4649-BC28-3A2C50850825
P2860
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@ast
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@en
type
label
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@ast
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@en
prefLabel
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@ast
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@en
P2093
P2860
P4510
P1433
P1476
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency
@en
P2093
Elizabeth G Cook
Frank Soldner
Maisam Mitalipova
P2860
P304
P356
10.1016/J.STEM.2008.08.014
P407
P577
2008-09-01T00:00:00Z